Periarticular Multimodal Drug Injections in Total Knee Arthroplasty
2012年12月15日 更新者:Tae Kyun Kim、Seoul National University Hospital
Efficacy and Safety of Periarticular Multimodal Drug Injections in Total Knee Arthroplasty
The purpose of this study is to determine whether periarticular multimodal drug injection (PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block, intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications.
We hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer and would provide better functional recovery and patient satisfaction.
We also hypothesized that the incidence of side effects and complications of the PMDI would be similar to the No-PMDI.
研究概览
地位
完全的
条件
详细说明
The preemptive multimodal approaches are regarded as a current standard pain management protocol.
Recently, periarticular multimodal drug injection (PMDI) has been considered to be one of the most effective and important component in multimodal approaches.
Because the contemporary pain management protocol using the regional anesthesia, continuous femoral nerve block (FNB) and intravenous patient-controlled analgesia (PCA) has been proved significantly improved analgesic effects itself, little information whether the PMDI would provide additional pain relief under this pain management protocol is available.
Also, because the safety of the high dose local anesthetics and narcotics has not been clarified, a selective application should be considered to patients who were expected to show better analgesia if there were certain patient related factors to predict the additional pain relief effect of the PMDI.
Thus, this prospective double-blind randomized study was conducted to determine whether PMDI would provide additional benefits in patients after total knee arthroplasty (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block, IV-PCA and preemptive oral medications in terms of pain relief, consumption of PCA and acute pain rescuer, patients satisfaction, functional recovery, side effects and complications.
研究类型
介入性
注册 (实际的)
101
阶段
- 第四阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Gyeonggi-do
-
Seongnam-si、Gyeonggi-do、大韩民国、463-707
- Joint Reconstruction Center, Seoul National University Bundang Hospital
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 81年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Diagnosis of primary osteoarthritis
- Scheduled for elective total knee arthroplasty
- Signed written informed consent
- Spinal anesthesia
Exclusion Criteria:
- Patients refusing consents
- inability to use the outcome assessment tools
- Contraindications to regional anesthesia
- severe cardiovascular disease
- allergy or contraindication to drugs used in this study
- pre-existing neurologic disease including psychiatric disorder
- drug abuser
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Periarticular Injection group
Periarticular injection with ropivacaine, morphine, ketorolac, epinephrine, cefuroxime
|
300mg (0.75%, 40cc) intraoperative periarticular injection
10mg intraoperative periarticular injection
30 mg intraoperative periarticular injection
300 microgram (1:1000) intraoperative periarticular injection
750mg intraoperative periarticular injection
|
|
无干预:No Injection group
usual postoperative care without periarticular injection
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Pain( Visual Analog Scale )
大体时间:the night after surgery
|
An independent investigator who was blinded to randomization assessed pain level using 0 to 10 visual analog scale (VAS) that ranged from 0 (no pain) to 10 (worst imaginable pain)at the night after operation.
|
the night after surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Intravenous Patient Controlled Analgesia(PCA) Consumption During 24 Hours After Surgery
大体时间:24 hours postoperative
|
Fentanyl based PCA consumption via PCA pump (microgram)
|
24 hours postoperative
|
|
Participant Number of Postoperative Nausea and Vomiting During 24 Hours After Surgery
大体时间:24 hours after surgery
|
An independent investigator assessed participant number of postoperative nausea and vomiting during 24 hours after surgery.
Nausea was defined as a subjective unpleasant sensation associated with awareness of the urge to vomit; and vomiting, as the forceful expulsion of gastric contents from the mouth.
|
24 hours after surgery
|
|
the Proportion of Patients Who Were Satisfied With the Pain Management
大体时间:postoperative 7 day
|
postoperative 7 day
|
|
|
The Proportion of Patients Who Could Raise Leg With Replaced Knee Extended
大体时间:24 hours postoperative
|
24 hours postoperative
|
|
|
Maximal Flexion Angle Degree on Postoperative 7 Day
大体时间:postoperative 7 day
|
An independent investigator measured the maximal flexion angle (degree) of replaced knee with 28 centimeter armed goniometer on postoperative 7 day
|
postoperative 7 day
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Tae Kyun Kim, MD, PhD、Joint Recontruction Center, Seoul National University Bundang hospital
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2008年4月1日
初级完成 (实际的)
2009年3月1日
研究完成 (实际的)
2009年4月1日
研究注册日期
首次提交
2009年5月13日
首先提交符合 QC 标准的
2009年5月13日
首次发布 (估计)
2009年5月14日
研究记录更新
最后更新发布 (估计)
2013年1月25日
上次提交的符合 QC 标准的更新
2012年12月15日
最后验证
2012年12月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- B-0804/056-021
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.